Cargando…
T cell perturbations persist for at least 6 months following hospitalization for COVID-19
COVID-19 is being extensively studied, and much remains unknown regarding the long-term consequences of the disease on immune cells. The different arms of the immune system are interlinked, with humoral responses and the production of high-affinity antibodies being largely dependent on T cell immuni...
Autores principales: | Govender, Melissa, Hopkins, Francis R., Göransson, Robin, Svanberg, Cecilia, Shankar, Esaki M., Hjorth, Maria, Nilsdotter-Augustinsson, Åsa, Sjöwall, Johanna, Nyström, Sofia, Larsson, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393525/ https://www.ncbi.nlm.nih.gov/pubmed/36003367 http://dx.doi.org/10.3389/fimmu.2022.931039 |
Ejemplares similares
-
SARS-CoV-2 Specific Antibody Response and T Cell-Immunity in Immunocompromised Patients up to Six Months Post COVID: A Pilot Study
por: Sjöwall, Johanna, et al.
Publicado: (2022) -
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
por: Hopkins, Francis R., et al.
Publicado: (2023) -
Pentameric C-reactive protein is a better prognostic biomarker and remains elevated for longer than monomeric CRP in hospitalized patients with COVID-19
por: Hopkins, Francis R., et al.
Publicado: (2023) -
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19
por: Enocsson, Helena, et al.
Publicado: (2021) -
Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report
por: Nyström, Katarina, et al.
Publicado: (2022)